| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |